CLL life expectancy: what the numbers really say | CION Cancer Clinics

No. CLL behaves so differently from person to person that no single number describes it. Many people live with it for many years, often without treatment, and die of something unrelated. For a smaller group it moves faster and needs treatment sooner.

Why this page gives no figure

Survival figures online are averages across thousands of people of different ages, stages and genetic results, many treated years ago. They cannot tell you where you or your parent sits. Putting a number here would look precise and be misleading. Instead, this page explains what shapes the outlook, so you can have a better conversation with your haematologist.

What prognosis means

Prognosis is the doctor's best estimate of how an illness is likely to behave in one person. In CLL it is built from several pieces: the stage, a few genetic tests, how fast the counts are changing, and your general health. It is revised as time passes and as tests are repeated.

What age has to do with it

CLL is mostly found in older adults. For many of them, heart disease, diabetes or kidney problems shape the years ahead more than the CLL does. That is one reason a younger and an older person with the same report can be told quite different things.

Most published figures look backwards. They describe people who were diagnosed and treated many years ago, before today's targeted medicines were widely used. The outlook for someone diagnosed now may be quite different.

An average hides the spread

CLL includes people who never need treatment and people who need it within a short time of diagnosis. An average across both groups describes almost nobody. Your own genetic results and stage matter far more than the middle of a chart.

Where the data come from

Much of the research comes from Europe and North America. People there are often diagnosed at a different age, through different routine tests, with different access to medicines. Figures from one country do not transfer neatly to a family in Telangana or Andhra Pradesh.

Access changes the picture

Whether a person can reach the right tests, the right medicine and steady follow-up makes a real difference. Schemes such as Aarogyasri and PM-JAY, and approved generic medicines, have changed what is possible for many families. Ask what is available to you now.

This page cannot tell you how long you or your parent will live. No page can. It also cannot tell you which group you belong to without your stage, genetic results and a doctor who has examined you.

Living with not knowing

Uncertainty is often the hardest part of CLL, especially when nothing is being treated. It helps to name one person in the family who keeps the reports and joins visits. It helps to write questions down before each appointment. Counselling is worth asking about if worry is taking over sleep or work.

Where CION fits

CION's haematology team, including Dr. Basudev Pokhrel, reviews the reports, discusses complex cases at a tumour board and explains what the results mean in plain words. If a test or treatment is needed elsewhere, the team coordinates it with a qualified centre.